Allene M. Diaz, Director at IONIS PHARMACEUTICALS INC (IONS), sold 109,756 shares at $79.11 ($8.7M) on 2026-03-03, disclosed to the SEC on 2026-03-05.
Open-market sale of $8.7M IONS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.11 | 39,265 | $3.1M | 35.7% |
| 2 | $79.11 | 39,265 | $3.1M | 35.7% |
| 3 | $79.88 | 14,608 | $1.2M | 13.4% |
| 4 | $79.88 | 14,608 | $1.2M | 13.4% |
| 5 | $80.80 | 1,005 | $81K | 0.9% |
| 6 | $80.80 | 1,005 |
| $81K |
| 0.9% |
| Total | $79.35 avg | 109,756 | $8.7M | 100% |
| Filing → |
| IONS | SELL | 2024-07-17 | $81K | — | Filing → |
| IONS | SELL | 2023-08-03 | $27K | — | Filing → |